Global Oncology Academy
The Global Oncology Academy (GOA) is an educational platform for physicians and other healthcare professionals involved in oncology. Its mission is to increase knowledge regarding the disease course of specific cancers and address key elements for successful management. The GOA series will also share the science around innovations in combination therapies, oncology strategies, and new developments.
For more information about GOA, visit www.globaloncologyacademy.org.
256-270 of 474
All Sides of the Joint: Integrated TGCT Care Across Specialties
MinuteCE®All Sides of the Joint: Integrated TGCT Care Across Specialties
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Chelsea Cole, MD
The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
MinuteCE®The Tumor That’s Not So Tiny: Understanding the Impact of TGCT
A.J. Gelderblom, MD, PhD
The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
MinuteCE®The Safety Equation: Managing Adverse Events Associated With CSF1R Inhibitors in TGCT
A.J. Gelderblom, MD, PhD
Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
MinuteCE®Surgical Crossroads: Practical Considerations for Optimizing Treatment in TGCT
A.J. Gelderblom, MD, PhD
Michiel van de Sande, MD, PhD
Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
MinuteCE®Applying the Evidence: TGCT Treatment Insights for Sports Medicine Physicians
A.J. Gelderblom, MD, PhD
Chelsea Cole, MD
Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
MinuteCE®Clinical Evidence in Focus: Interpreting Data on Systemic Therapy Targeting CSF1R
A.J. Gelderblom, MD, PhD
- advertisement
Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
MinuteCE®Beyond the Scalpel: When TGCT Surgery Isn’t the Solution
Michiel van de Sande, MD, PhD
Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
MinuteCE®Emerging Evidence in Focus: Interpreting Data on Next-Generation CSF1R TKIs
A.J. Gelderblom, MD, PhD
Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
Project Oncology®Growth Recovery After Tovorafenib in Pediatric Low-Grade Gliomas: New Data
Alexandria May, PharmD, BCPS
Daniel Landi, MD
Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Project Oncology®Advancing Endometrial Cancer Care: Molecular Targets and Emerging Therapies
Casey Cosgrove, MD
Reducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors
Project Oncology®Reducing Endometrial Cancer Risk: Targeting Modifiable Risk Factors
Brian Slomovitz, MD
Unmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity
Project Oncology®Unmet Needs in Endometrial Cancer: Bridging Gaps in Treatment and Equity
Brian Slomovitz, MD
- advertisement
Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
Project Oncology®Modern Era, New Outcomes: Survival Trends in Breast Cancer Brain Metastases
Ryan Quigley
Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
Project Oncology®Targeting Ribosome Maturation: A Preclinical Strategy for Triple-Negative Breast Cancer
Ryan Quigley
Dexamethasone Timing and Infusion Reactions in HER2+ Breast Cancer
Project Oncology®Dexamethasone Timing and Infusion Reactions in HER2+ Breast Cancer
